CAS No 900161-13-9 (1R,3aR,4aR,8aR,9S,9aR)-1-methyl-3-oxodecahydro-3H-spiro[naphtho[2,3-c]furan-6,2'-[1,3]dioxolane]-9-carboxylic acid Pharmaceutical Intermediates

Introducing (1R,3aR,4aR,8aR,9S,9aR)-1-methyl-3-oxodecahydro-3H-spiro[naphtho[2,3-c]furan-6,2'-[1,3]dioxolane]-9-carboxylic acid, a complex compound designed for the pharmaceutical industry. Produced in our integrated manufacturing and trading facilities, the product is characterized by high quality and efficacy. Key selling points include:

- Unique Chemical Structure: Innovative spirocyclic compound design enhances its therapeutic potential.
- High Purity Standard: Produced under strict quality control measures to ensure optimal efficacy.
- Multiple Applications: Suitable for various drug formulations and therapeutic areas.
- Reliable supply chain: Backed by strong production capacity and timely delivery.

product details

Product details

Product detail

Chemical properties:

(1R,3aR,4aR,8aR,9S,9aR)-1-methyl-3-oxodecahydro-3H-spiro[naphtho[2,3-c]furan-6,2'-[1,3]dioxolane]-9-carboxylic acid is a complex organic compound with unique stereochemistry that contributes to its biological activity. The compound has a spirocyclic structure that combines a naphthofuran core with a dioxolane moiety, providing the basis for its potential therapeutic applications.

- Molecular formula: C17H25NO6

-Molecular weight:339.38 g/mol

- Appearance: White to off-white powder

- Solubility: Soluble in organic solvents; limited solubility in water

- Melting Point: Specific melting point data available upon request

product detail

CAS No.	40856-44-8
EINECS	609-874-3
Formula	C9H11NO2
Molecular Weight	165.19
Appearance	White to Off-White solid
Purity	≥98%
Type	Pharmaceutical Intermediates

Advantages

1. Innovative mechanism of action: The unique spirocyclic structure of the compound can interact with biological systems in a targeted manner, thereby enhancing its therapeutic effect. This makes it a valuable candidate for drug development in various therapeutic areas such as oncology and neurology.

2. High Purity and Quality Assurance: Our integrated production facilities follow strict quality control measures to ensure that every batch of (1R,3aR,4aR,8aR,9S,9aR)-1-methyl-3-oxodecahydro-3H-spiro[naphtho[2,3-c]furan-6,2'-[1,3]dioxolane]-9-carboxylic acid meets high purity standards. This is critical for pharmaceutical applications where efficacy and safety are paramount.

3. Versatile Drug Applications: This compound can be used in a variety of drug formulations, including oral, injectable, and topical preparations. Its versatility makes it an attractive option for pharmaceutical companies seeking to expand their product lines and meet the needs of different patients.

4. Established Safety: Extensive research and testing have been conducted to evaluate the safety and effectiveness of this compound, providing confidence for healthcare providers to use it in clinical settings.

Text description:

(1R,3aR,4aR,8aR,9S,9aR)-1-methyl-3-oxodecahydro-3H-spiro[naphtho[2,3-c]furan-6,2'-[1,3]dioxolane]-9-carboxylic acid is a cutting-edge pharmaceutical compound that plays an important role in modern drug development. Its unique chemical structure, characterized by a spiro ring configuration and the combination of naphthofuran and dioxolane components, lays the foundation for its potential therapeutic applications.

Our integrated manufacturing and trading facilities are dedicated to providing high quality (1R,3aR,4aR,8aR,9S,9aR)-1-methyl-3-oxodecahydro-3H-spiro[naphtho[2,3-c]furan-6,2'-[1,3]dioxolane]-9-carboxylic acid that meets the stringent requirements of the pharmaceutical industry. We use advanced manufacturing techniques and adhere to strict quality control procedures to ensure that our products are of the highest purity and potency. Each batch of products is thoroughly tested to guarantee compliance with industry standards, giving our customers confidence in the quality of our products.

The compound's novel mechanism of action enables targeted therapeutic effects, making it a valuable candidate for drug development in various therapeutic areas. Its ability to interact with specific biological targets enhances its potential therapeutic efficacy, paving the way for innovative treatment options in the pharmaceutical market.

In addition to its clinical benefits, (1R,3aR,4aR,8aR,9S,9aR)-1-methyl-3-oxodecahydro-3H-spiro[naphtho[2,3-c]furan-6,2'-[1,3]dioxolane]-9-carboxylic acid has versatility in pharmaceutical applications. It can be formulated into a variety of dosage forms, including oral tablets, injections, and topical preparations, to meet the needs and preferences of different patients. This versatility is critical for pharmaceutical companies looking to expand their product offerings and meet market demand.

As a trusted partner to the pharmaceutical industry, our company is committed to providing a reliable supply of (1R,3aR,4aR,8aR,9S,9aR)-1-methyl-3-oxodecahydro-3H-spiro[naphtho[2,3-c]furan-6,2'-[1,3]dioxolane]-9-carboxylic acid. Our strong production capabilities ensure that we can meet our customers' needs while maintaining competitive pricing and timely delivery. We understand the importance of having a reliable supply of critical drugs, and we strive to exceed our customers' expectations in every aspect of our service.

In summary

In conclusion, (1R,3aR,4aR,8aR,9S,9aR)-1-methyl-3-oxodecahydro-3H-spiro[naphtho[2,3-c]furan-6,2'-[1,3]dioxolane]-9-carboxylic acid is an essential compound for pharmaceutical applications. With its unique structure, high purity, and versatile applications, it is a top choice for healthcare providers and pharmaceutical companies. Trust our integrated facility to meet your pharmaceutical needs and experience the difference in quality and service. Contact us today to learn more about this innovative compound and how we can support your pharmaceutical endeavors.